Dermoscopy in Family Practice: Worth It—or Waste of Time?

If you're a family practitioner, here's a scenario you may know all too well: A patient presents with a skin lesion that concerns them and asks you to take a look. On exam, it’s not quite suspicious enough to justify a biopsy—but it also doesn’t have the classic appearance of a benign lesion.

For many, the default move is a referral to dermatology. But then reality hits: the local dermatologist is so booked out that their next available appointment is over two months away. So you're left wondering—can anything be done on the "front lines" to improve this patient's outcome? Or is it simply too unrealistic to think that anyone except the dermatologist can safely triage these ambiguous lesions?

Enter dermoscopy. By using a handheld magnification device, dermoscopy allows clinicians the ability to visualize the hidden colors, structures, and patterns which can reveal the true nature of any given lesion. Yet, many primary care physicians hesitate to adopt it, assuming that learning dermoscopy requires an unrealistic investment of time.

But does it really?

Several studies have shown that primary care clinicians can meaningfully improve their diagnostic accuracy with relatively brief, structured dermoscopy training. In one study, clinicians completed approximately two to three hours of combined training and saw their real-world diagnostic accuracy improve from roughly 40% to over 70% in the year that followed¹. That’s not simply an improvement on image-based testing—it reflects a change in how clinicians are making decisions in actual clinical practice.

Other studies show similar patterns. A Canadian study involving family physicians who participated in a single 3.5-hour training session demonstrated improvements in overall diagnostic accuracy from 76.4% to 90.8%, with melanoma detection accuracy reaching 95%². Importantly, this was not accompanied by indiscriminate increases in procedures. In fact, the rate of unnecessary biopsies of benign lesions decreased, suggesting that dermoscopy can improve both sensitivity and specificity in a practical setting.

Even shorter training interventions have shown meaningful effects. In one study, approximately 75 minutes of focused instruction increased skin cancer detection sensitivity from 62.5% to 88.1%, while maintaining high specificity³.

Taken together, these findings suggest that dermoscopy is not a skill that requires prolonged immersion to begin using effectively, particularly when the goal is not subspecialty-level diagnosis, but improved triage.

This distinction is important, because it reframes what dermoscopy is actually meant to do in primary care.

Dermoscopy is not about turning primary care physicians into dermatologists, nor is it about making definitive diagnoses for every lesion encountered. Instead, it functions as a tool to improve decision-making in a much narrower and more practical sense: determining whether a lesion is clearly benign, whether it warrants biopsy, or whether it should be referred for further evaluation. When viewed through that lens, the expectations become far more realistic and aligned with the daily workflow of primary care.

Primary care is where most of this starts.

Most patients don’t walk into dermatology first—they walk into your office. At the same time, dermatology access can be limited depending on the practice setting, and a significant proportion of visits involve dermatologic concerns⁴. Many of these cases involve lesions in the "gray zone" we previously described—lesions which are neither clearly benign nor clearly malignant on visual inspection alone.

Traditionally, many primary care physicians have relied on a straightforward approach: if a lesion is suspicious, refer it.

Dermoscopy allows for a more nuanced workflow:

• Clearly benign lesions can be reassured
• Suspicious but appropriate lesions can be biopsied in-office
• Complex or high-risk lesions can still be referred

Referral remains essential, but dermoscopy helps refine how often—and how urgently—it is needed.

Although few are willing to openly admit it, economics does play a role when adopting new skills or modifying clinical workflow. We all want better outcomes for our patients—but not at the expense of the clinic’s financial sustainability.

Dermoscopy should not be approached as a revenue tool, but it can strengthen clinical decision-making in a way that leads to appropriate, reimbursable procedures. When biopsies are guided by dermoscopic findings, they remain firmly within the ethical and clinical scope of primary care. And when weighed against the relatively low time and overhead required, these procedures can help support—rather than strain—the clinic’s bottom line.

As a general reference point (recognizing variability by geography and payer):

• Tangential (shave) biopsy (CPT 11102): approximately $90–$100
• Punch biopsy (CPT 11104): approximately $120+

The goal of highlighting these figures isn't to encourage unnecessary biopsies. Instead, it’s to address a very real, practical concern: while integrating dermoscopy requires an initial investment of time and resources, it can provide a measurable return that supports the financial health of your practice.

Survey data suggest that the primary barriers to dermoscopy use are not related to difficulty, but to access and training.

Most primary care physicians do not currently use dermoscopy or have formal training, yet approximately 87% express interest in learning⁵. The most commonly cited obstacles are lack of access to a dermatoscope and lack of training opportunities.

This suggests that dermoscopy is not being avoided because it is impractical, but because many clinicians have simply not been exposed to it in a structured way.

The evidence suggests that it is, provided the goal is appropriately defined.

This is not about mastering dermatology or achieving perfect diagnostic accuracy. It's about improving the quality of decisions that are already being made every day in primary care. With relatively modest training, clinicians can become more confident in distinguishing benign from suspicious lesions, more selective in their use of biopsy, and more precise in determining when referral is necessary.

Dermoscopy does not fundamentally change the role of the primary care physician in skin cancer evaluation. It simply improves it.

Dermoscopy isn’t a departure from primary care—it’s an enhancement of something you’re already doing. It provides better visualization, improves pattern recognition, and supports more confident decision-making.

Not perfect. But meaningfully better. And in primary care, that’s usually what matters most.